Hepatic encephalopathy: An approach to its multiple pathophysiological features

World Journal of Hepatology

Volumn 4, Issue 3, 2012, Pages 50-65

  Perazzo, Juan Carlos ^a   Tallis, Silvina ^a   Delfante, Amalia ^a   Souto, Pablo Andrés ^a   Lemberg, Abraham ^a   Eizayaga, Francisco Xavier ^a   Romay, Salvador ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b General Hospital I Pirovano GCBA   (Argentina)

Author keywords

Ammonia and central nervous system; Hepatic encephalopathy; Hyperammonemia; Liver failure

Indexed keywords

EID: 84866127947     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v4.i3.50     Document Type: Editorial

References (183)

1. Amodio P. The liver, the brain and nitrogen metabolism. Metab Brain Dis 2009; 24: 1-4
2. Norenberg MD. The Astrocyte in Liver Disease. In: Fedoraff S, Hertz L, editors. Advances in Cellular and Neurobiology. New York: Academic Press, 1981: 304-352
3. Lockwood AH, Yap EW, Rhoades HM, Wong WH. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 11 : 331-336
4. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002; 36: 1163-1171
5. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 789-796
6. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
7. Quadrennial reviews and working party reports from the World Congress in Gastroenterology. February 24-March 1, 2002. Bangkok, Thailand. J Gastroenterol Hepatol 2002; 17 Suppl: S1-S195
8. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25 Suppl 1: 11-16
9. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 2009; 29: 783-788
10. Blei AT. Hepatic Encephalopathy in Acute Liver Failure. In: Haussinger D, Kircheiss G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. London-Heidelberg: Springer, 2006: 433-441
11. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, Lee WM, Blei AT. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125: 755-764
12. Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2003; 2: 12-22
13. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475-1480
14. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46: 1844-1852
15. Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F. Acute-onchronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011; 5: 523-537; quiz 537
16. Weber FL, Friedman DW, Fresard KM. Ammonia production from intraluminal amino acids in canine jejunum. Am J Physiol 1988; 254: G264-G268
17. Desjardins P, Rao KV, Michalak A, Rose C, Butterworth RF. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle. Metab Brain Dis 1999; 14: 273-280
18. He Y, Hakvoort TB, Köhler SE, Vermeulen JL, de Waart DR, de Theije C, ten Have GA, van Eijk HM, Kunne C, Labruyere WT, Houten SM, Sokolovic M, Ruijter JM, Deutz NE, Lamers WH. Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification. J Biol Chem 2010; 285: 9516-9524
19. Córdoba J, López-Hellín J, Planas M, Sabín P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004; 41: 38-43
20. Les I, Doval E, Garcïa-Martínez R, Planas M, Cärdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: A randomized study. Am J Gastroenterol 2011; 106: 1081-1088
21. Olde Damink SW, Jalan R, Dejong CH. Interorgan ammonia trafficking in liver disease. Metab Brain Dis 2009; 24: 169-181
22. Wright G, Noiret L, Olde Damink SW, Jalan R. Interorgan ammonia metabolism in liver failure: The basis of current and future therapies. Liver Int 2011; 31: 163-175
23. Eggers J, Pade O, Rogge A, Schreiber SJ, Valdueza JM. Transcranial color-coded sonography successfully visualizes all intracranial parts of the internal carotid arte ry using the combined transtemporal axial and coronal approach. AJNR Am J Neuroradiol 2009; 30: 1589-1593
24. Bishop JM, Verlander JW, Lee HW, Nelson RD, Weiner AJ, Handlogten ME, Weiner ID. Role of the Rhesus glycoprotein, Rh B glycoprotein, in renal ammonia excretion. Am J Physiol Renal Physiol 2010; 299: F1065-F1077
25. Lee HW, Verlander JW, Bishop JM, Nelson RD, Handlogten ME, Weiner ID. Effect of intercalated cell-specific Rh C glycoprotein deletion on basal and metabolic acidosis-stimulated renal ammonia excretion. Am J Physiol Renal Physiol 2010; 299: F369-F379
26. Kalaitzakis E, Björnsson E. Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastroenterol 2007; 42: 1238-1244
27. Keen CL, Fransson GB, Lönnerdal B. Supplementation of milk with iron bound to lactoferrin using weanling mice. II: Effects on tissue manganese, zinc, and copper. J Pediatr Gastroenterol Nutr 1984; 3: 256-261
28. Scheuhammer AM, Cherian MG. Binding of manganese in human and rat plasma. Biochim Biophys Acta 1985; 840: 163-169
29. Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 1999; 20: 173-180
30. Takeda A. Manganese action in brain function. Brain Res Brain Res Rev 2003; 41: 79-87
31. Desole MS, Sciola L, Delogu MR, Sircana S, Migheli R. Manganese and 1-methyl-4-(2'-ethylpheny1)-1,2,3,6-tetrahydropyridine induce apoptosis in PC12 cells. Neurosci Lett 1996; 209: 193-196
32. Hirata Y, Adachi K, Kiuchi K. Activation of JNK pathway and induction of apoptosis b y manganese in PC12 cells. J Neurochem 1998; 71: 1607-1615
33. Bonilla E, Arrieta A, Castro F, Dávila JO, Quiroz I. Manganese toxicity: Free amino acids in the striatum and olfactory bulb of the mouse. Invest Clin 1994; 35: 175-181
34. Takeda A, Sotogaku N, Oku N. Manganese influences the levels of neurotransmitters in synapses in rat brain. Neuroscience 2002; 114: 669-674
35. Tomás-Camardiel M, Herrera AJ, Venero JL, Cruz Sánchez-Hidalgo M, Cano J, Machado A. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Brain Res Mol Brain Res 2002; 103: 116-129
36. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270-274
37. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, Lebrun LH, Zayed J, Leblanc A, Pomier-Layrargues G. Increased blood manganese in cirrhotic patients: Relationship to p allid al magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24: 1116-1120
38. Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 2000; 32: 171-180
39. Papavasiliou PS, Miller ST, Cotzias GC. Role of liv e r in regulating distribution and excretion of manganese. Am J Physiol 1966; 211: 211-216
40. Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, Spahr L, Huet PM, Pomier-Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-644
41. Siger-Zajdel M, Selmaj K. Hyperintense basal ganglia on T1- weighted magnetic resonance images in a patient with common variable immunodeficiency associated with elevated serum manganese. J Neuroimaging 2002; 12: 84-86
42. Sassine MP, Mergler D, Bowler R, Hudnell HK. Manganese accentuates adverse mental health effects associated with alcohol use disorders. Biol Psychiatry 2002; 51: 909-921
43. Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994; 36: 871-875
44. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996; 23: 95-98
45. Frausto da Silva JJR, Williams RJP. The Biological Chemistry of the Elements. The Inorganic Chemistry of Life. Oxford: Clarendon Press, 1991: 122-144
46. Bjerring PN, Eefsen M, Larsen FS, Bernal W, Wendon J. Hypermagnesemia does not prevent intracranial hypertension and aggravates cerebral hyperperfusion in a rat model of acute hyperammonemia. Hepatology 2011; 53: 1986-1994
47. Norenberg MD. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab Invest 1977; 36: 618-627
48. Martinez A . Electron microscopy in human hepatic encephalopathy. Acta Neuropathol 1968; 11 : 82-86
49. Traber P, DalCanto M, Ganger D, Blei AT. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization. Gastroenterology 1989; 96: 885-891
50. Gregorios JB, Mozes LW, Norenberg MD. Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies. J Neuropathol Exp Neurol 1985; 44: 404-414
51. Kallaras C, Anogianakis G, Apostolakis M, Manthos A, Sioga A, Economou L, Foroglou C. Ultrastructural alterations of the rabbit sciatic nerve, spinal cord and cerebellum, following methionine sulphoximine administration. Histol Histopathol 1994; 9: 105-112
52. Aitken PG, Borgdorff AJ, Juta AJ, Kiehart DP, Somjen GG, Wadman WJ. Volume changes induced by osmotic stress in freshly isolated rat hippocampal neurons. Pflugers Arch 1998; 436: 991-998
53. Norenberg MD, Jayakumar AR, Rama Rao KV. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2004; 19: 313-329
54. Haussinger D, Gorg B, Reinehr R, Schliess F. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy. Metab Brain Dis 2005; 20: 285-294
55. Häussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem Int 2005; 47: 64-70
56. Albrecht J, Norenberg MD. Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 2006; 44: 788-794
57. Lores-Arnaiz S, Perazzo JC, Prestifilippo JP, Lago N, D'Amico G, Czerniczyniec A, Bustamante J, Boveris A, Lemberg A. Hippocampal mitochondrial dysfunction with decreased mtNOS activity in prehepatic portal hypertensive rats. Neurochem Int 2005; 47: 362-368
58. Bustamante J, Lores-Arnaiz S, Tallis S, Roselló DM, Lago N, Lemberg A, Boveris A, Perazzo JC. Mitochondrial dysfunction as a mediator of hippocampal apoptosis in a model of hepatic encephalopathy. Mol Cell Biochem 2011; 354: 231-240
59. Chrispeels MJ, Agre P. Aquaporins: Water channel proteins of plant and animal cells. Trends Biochem Sci 1994; 19: 421-425
60. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003; 4 : 991-1001
61. Badaut J, Regli L. Distribution and possible roles of aquaporin 9 in the brain. Neuroscience 2004; 129: 971-981
62. Kimelberg HK. Water transport in the brain: Basic concepts an d astrocytic swelling . In: Haussinger D, Kircheiss G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. London-Heidelberg: Springer, 2006: 3-19
63. Jayakumar AR, Liu M, Moriyama M, Ramakrishnan R, Forbush B, Reddy PV, Norenberg MD. Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J Biol Chem 2008; 283: 33874-33882
64. Haussinger D, Gorg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care 2010; 13: 87-92
65. Cserr HF, DePasquale M, Nicholson C, Patlak CS, Pettigrew KD, Rice ME. Extracellular volume decreases while cell volume is maintained b y ion uptake in rat brain during acute hypernatremia. J Physiol 1991; 442: 277-295
66. Nicholson C, Syková E. Extracellular space structure revealedby diffusion analysis. Trends Neurosci 1998; 2 1 : 207-215
67. Verbalis JG, Gullans SR. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res 1993; 606: 19-27
68. Kimelberg HK, Goderie SK, Conley PA, Higman S, Goldschmidt R, Amundson RH. Uptake of [3H]serotonin and [3H]glutamate b y p rimary astrocyte cultures. I. Effects of different sera and time in culture. Glia 1992; 6: 1-8
69. Hansson E, Rönnbäck L. Astroglial modulation of synaptic transmission. Perspect Dev Neurobiol 1994; 2: 217-223
70. Svoboda J, Syková E. Extracellular space volume changes in the rat spinal cord produced by nerve stimulation and peripheral injury. Brain Res 1991; 560: 216-224
71. Simonová Z, Svoboda J, Orkand P, Bernard CC, Lassmann H, Sykova E. Changes of extracellular space volume and tortuosity in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Physiol Res 1996; 45: 11-22
72. Krizaj D, Rice ME, Wardle RA, Nicholson C. Water compartmentalization and extracellular tortuosity after osmotic changes in cerebellum of Trachemys scripta. J Physiol 1996; 492 (Pt 3): 887-896
73. Chvátal A, Pastor A, Mauch M, Sykova E, Kettenmann H. Distinct populations of identified glial cells in the developing rat spinal cord slice: ion channel properties and cell morphology. Eur J Neurosci 1995; 7: 129-142
74. Pasantes Morales H, Schousboe A. Volume regulation in astrocytes: A role for taurine as an osmoeffector. J Neurosci Res 1988; 20: 503-509
75. Pasantes-Morales H, Franco R, Torres-Marquez ME, Hernandez-Fonseca K, Ortega A. Amino acid osmolytes in regulal tory volume decrease and isovolumetric regulation in brain cells: Contribution and mechanisms. Cell Physiol Biochem 2000; 10: 361-370
76. Syková E. Glial diffusion barriers during aging and pathological states. Prog Brain Res 2001; 132: 339-363
77. Hoffmann EK, Lambert IH, Pedersen SF. Physio logy of cell volume regulation in vertebrates. Physiol Rev 2009; 89: 193-277
78. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Bloodbrain barrier: Structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006; 1 : 223-236
79. Correale J, Villa A. Cellular elements of the blood-brain barrier. Neurochem Res 2009; 34: 2067-2077
80. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13
81. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-653
82. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 1979; 63: 449-460
83. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, Arroliga AC, Mullen KD. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188-193
84. Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P, Madl C. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31: 30-34
85. Goldbecker A, Buchert R, Berding G, Bokemeyer M, Lichtinghagen R, Wilke F, Ahl B, Weissenborn K. Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls. J Cereb Blood Flow Metab 2010; 30: 1384-1393
86. Stahl J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med 1963; 58: 1-24
87. Lockwood AH, Finn RD, Campbell JA, Richman TB. Factors that affect the uptake of ammonia by the brain: The bloodbrain pH gradient. Brain Res 1980; 181: 259-266
88. Jensen MB, Finsen B, Zimmer J. Morphological and immunophenotypic microglial changes in the denervated fascia dentata of adult rats: Correlation with blood-brain barrier damage and astroglial reactions. Exp Neurol 1997; 143: 103-116
89. Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010; 139: 675-684
90. Engelhardt B, Sorokin L. The blood-brain and the bloodcerebrospinal fluid barriers: Function and dysfunction. Semin Immunopathol 2009; 31: 497-511
91. Dalkara T, Gursoy-Ozdemir Y, Yemisci M. Brain microvascular pericytes in health and disease. Acta Neuropathol 2011; 122: 1-9
92. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010; 468: 557-561
93. Jiménez B, Montoliu C, MacIntyre DA, Serra MA, Wassel A, Jover M, Romero-Gomez M, Rodrigo JM, Pineda-Lucena A, Felipo V. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance. J Proteome Res 2010; 9: 5180-5187
94. Eizayaga F, Scorticati C, Prestifilippo JP, Romay S, Fernandez MA, Castro JL, Lemberg A, Perazzo JC. Altered bloodbrain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is lowered. World J Gastroenterol 2006; 12: 1367-1372
95. Scorticati C, Prestifilippo JP, Eizayaga FX, Castro JL, Romay S, Fernandez MA, Lemberg A, Perazzo JC. Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication. World J Gastroenterol 2004; 10: 1321-1324
96. Szerb JC, Butterworth RF. Effect of ammoniumions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol 1992; 39: 135-153
97. Felipo V, Butterworth RF. Mitochondrial dysfunction in acute hyperammonemia. Neurochem Int 2002; 40: 487-491
98. McCandless DW, Schenker S. Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. Exp Brain Res 1981; 44: 325-330
99. Kosenko E, Kaminsky Y, Grau E, Miñana MD, Marcaida G, Grisolía S, Felipo V. Brain ATP depletion induced by acute ammonia intoxication in rats is m ediated by activation of the NMDA receptor and Na+,K(+)-ATPase. J Neurochem 1994; 63: 2172-2178
100. Butterworth RF. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 2007; 22: 309-320
101. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 2002; 67: 259-279
102. Kosenko E, Kaminski Y, Lopata O, Muravyov N, Felipo V. Blocking NMDA receptors prevents the oxidative stress induced by acute ammonia intoxication. Free Radic Biol Med 1999; 26: 1369-1374
103. Kosenko E, Kaminsky Y, Stavroskaya IG, Felipo V. Alteration of mitochondrial calcium homeostasis b y ammoniainduced activation of NMDA receptors in rat brain in vivo. Brain Res 2000; 880: 139-146
104. van Breemen C, Saida K. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol 1989; 51: 315-329
105. Pozzan T, Rizzuto R, Volpe P, Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 1994; 74: 595-636
106. Clapham DE. Calcium signaling. Cell 1995; 80: 259-268
107. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7: 369-379
108. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205
109. Sambrook JF. The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell 1990; 61: 197-199
110. Putney JW. Capacitative calcium entry revisited. Cell Calcium 1990; 11: 611-624
111. Putney JW, Bird GS. The signal for capacitative calcium entry. Cell 1993; 75: 199-201
112. Hermenegildo C, Monfort P, Felipo V. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: Characterization by in vivo brain microdialysis. Hepatology 2000; 31: 709-715
113. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315-360
114. Hepler PK. Calcium and mitosis. Int Rev Cytol 1992; 138: 239-268
115. Hepler PK. The role of calcium in cell division. Cell Calcium 1994; 16: 322-330
116. Nicotera P, Zhivotovsky B, Bellomo G, Orrenius S. Ion signalling in apoptosis. In: Apoptosis. New York: Plenum Press, 1994: 97-110
117. Nicotera P, Bellomo G, Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 1992; 32: 449-470
118. Giordano FJ, He H, McDonough P, Meyer M, Sayen MR, Dillmann WH. Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients. Circulation 1997; 96: 400-403
119. Cheung KH, Shineman D, Müller M, Cárdenas C, Mei L, Yang J, Tomita T, Iwatsubo T, Lee VM, Foskett JK. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008; 58: 871-883
120. Wittmann M, Queisser G, Eder A, Wiegert JS, Bengtson CP, Hellwig A, Wittum G, Bading H. Synaptic activity induces dramatic changes in the geometry of the cell nucleus: Interplay between nuclear structure, histone H3 phosphorylation, and nuclear calcium signaling. J Neurosci 2009; 29: 14687-14700
121. Queisser G, Wiegert S, Bading H. Structural dynamics of the cell nucleus: Basis for morphology modulation of nuclear calcium signaling and gene transcription. Nucleus 2011; 2: 98-104
122. Bootman MD, Fearnley C, Smyrnias I, MacDonald F, Roderick HL. An update on nuclear calcium signalling. J Cell Sci 2009; 122: 2337-2350
123. Ma TS, Mann DL, Lee JH, Gallinghouse GJ. SR compartment calcium and cell apoptosis in SERCA overexpression. Cell Calcium 1999; 26: 25-36
124. Panickar KS, Jayakumar AR, Rama Rao KV, Norenberg MD. Downregulation of the 18-kDa translocator protein: Effects on the ammonia-induced mitochondrial permeability transition and cell swelling in cultured astrocytes. Glia 2007; 55: 1720-1727
125. Roselló DM, Balestrasse K, Coll C, Coll S, Tallis S, Gurni A, Tomaro ML, Lemberg A, Perazzo JC. Oxidative stress and hippocampus in a low-grade hepatic encephalopathy model: Protective effects of curcumin. Hepatol Res 2008; 38: 1148-1153
126. Parola AL, Yamamura HI, Laird HE. Peripheral-type benzodiazepine receptors. Life Sci 1993; 52: 1329-1342
127. Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002; 40: 475-486
128. Itzhak Y, Roig-Cantisano A, Dombro RS, Norenberg MD. Acute liver failure and hyperammonemia increase peripheral- type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995; 705: 345-348
129. Shiraishi T, Black KL, Ikezaki K, Becker DP. Peripheral benzodiazepine induces morphological changes and proliferation of mitochondria in glioma cells. J Neurosci Res 1991; 30: 463-474
130. Hirsch JD, Beyer CF, Malkowitz L, Beer B, Blume AJ. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol 1989; 35: 157-163
131. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 2002; 84: 241-250
132. Azarashvili T, Grachev D, Krestinina O, Evtodienko Y, Yurkov I, Papadopoulos V, Reiser G. The peripheral-type benzodiazepine receptor is involved in control of Ca2+- induced permeability transition pore opening in rat brain mitochondria. Cell Calcium 2007; 42: 27-39
133. Bélanger M, Desjardins P, Chatauret N, Rose C, Butterworth RF. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J Hepatol 2005; 42: 694-699
134. Cagnon L, Braissant O. Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells. Neurobiol Dis 2008; 32: 281-292
135. Cagnon L, Braissant O. Hyperammonemia-induced toxicity for the developing central nervous system. Brain Res Rev 2007; 56: 183-197
136. Braissant O. Ammonia toxicity to the brain: Effects on creatine metabolism and transport and protective roles of creatine. Mol Genet Metab 2010; 100 Suppl 1: S53-S58
137. Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009; 1792: 3-13
138. Kosenko E, Kaminsky Y, Solomadin I, Marov N, Venediktova N, Felipo V, Montoliu C. Acute ammonia neurotoxicity in vivo involves increase in cytoplasmic protein P53 without alterations in other markers of apoptosis. J Neurosci Res 2007; 85: 2491-2499
139. Kimelberg HK, Anderson E, Kettenmann H. Swelling-induced changes in electrophysiological properties of cultured astrocytes and oligodendrocytes. II. Whole-cell currents. Brain Res 1990; 529: 262-268
140. Kimelberg HK, Goderie SK, Higman S, Pang S, Waniewski RA. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 1990; 10: 1583-1591
141. Schliess F, Haussinger D. The cellularhyd ration state: Role in apoptosis and proliferation. S ignal Transduction- Receptors, Mediators and Genes. Signal Transduction 2005; 6: 297-302
142. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407: 802-809
143. Jessica Chen M, Sepramaniam S, Armugam A, Shyan Choy M, Manikandan J, Melendez AJ, Jeyaseelan K, Sang Cheung N. Water and ion channels: Crucial in the initiation and progression of apoptosis in central nervous system? Curr Neuropharmacol 2008; 6: 102-116
144. Debska G, May R, Kicinska A, Szewczyk A, Elger CE, Kunz WS. Potassium channel openers depolarize hippocampal mitochondria. Brain Res 2001; 892: 42-50
145. Jentsch TJ. Neuronal KCNQ potassium channels: Physiology and role in disease. Nat Rev Neurosci 2000; 1 : 21-30
146. Xiao AY, Wei L, Xia S, Rothman S, Yu SP. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 2002; 22: 1350-1362
147. d'Anglemont de Tassigny A, Souktani R, Henry P, Ghaleh B, Berdeaux A. Volume-sensitive chloride channels (ICl,vol) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes. Fundam Clin Pharmacol 2004; 18: 531-538
148. da Silva CM, Macias-Garcia B, Miro-Moran A, Gonzalez-Fernandez L, Morillo-Rodriguez A, Ortega-Ferrusola C, Gallardo-Bolanos JM, Stilwell G, Tapia JA, Pena FJ. Melatonin reduces lipid peroxidation and apoptotic-like changes in stallion spermatozoa. J Pineal Res 2011; 51: 172-179
149. He W, Li H, Min X, Liu J, Hu B, Hou S, Wang J. Activation of volume-sensitive Cl(-) channel is involved in carboplatininduced apoptosis in human lun g adenocarcinoma cells. Cancer Biol Ther 2010; 9: 885-891
150. Bortner CD, Sifre MI, Cidlowski JA. New approaches for determining apoptotic volume decrease in cells. Methods Enzymol 2007; 428: 161-181
151. Abdullaev IF, Rudkouskaya A, Schools GP, Kimelberg HK, Mongin AA. Pharmacological comparison of swellingactivated excitatory amino acid release and Cl- currents in cultured rat astrocytes. J Physiol 2006; 572: 677-689
152. Davidson MM, Walker WF, Hernandez-Rosa E. The m.3243A > G mtDNA mutation is pathogenic in an in vitro model of the human blood brain barrier. Mitochondrion 2009; 9: 463-470
153. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007; 116: 1-14
154. Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, Mao X, Shanske S, Hirano M, DiMauro S, De Vivo DC. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004; 62: 1297-1302
155. Li J, Zhou K, Meng X, Wu Q, Li S, Liu Y, Wang J. Increased ROS generation and SOD activity in heteroplasmic tissues of transmitochondrial mice with A3243G mitochondrial DNA mutation. Genet Mol Res 2008; 7: 1054-1062
156. Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: Basic concepts, clini- 169 cal phenotype, and therapeutic management of MELAS syndrome. Ann NY Acad Sci 2008; 1142: 133-158
157. Tanji K, Kunimatsu T, Vu TH, Bonilla E. Neuropathological 170 features of mitochondrial disorders. Semin Cell Dev Biol 2001; 12: 429-439
158. Pallotti F, Baracca A, Hernandez-Rosa E, Walker WF, Solaini G, Lenaz G, Melzi D'Eril GV, Dimauro S, Schon EA, Da- 171 vidson MM. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J 2004; 384: 287-293
159. Pang CY, Lee HC, Wei YH. Enhanced oxidative damage in 172 human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of 173 mitochondrial diabetes. Diabetes Res Clin Pract 2001; 54 Suppl 2: S45-S56
160. Lagrange P, Romero IA, Minn A, Revest PA. Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic Biol Med 1999; 27: 667-672
161. Scorticati C, Perazzo JC, Rettori V, McCann SM, De Laurentiis A. Role of ammonia and nitric oxide in the decrease in plasma prolactin levels in prehepatic portal hypertensive male rats. Neuroimmunomodulation 2006; 13: 152-159
162. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957; 20: 11-21
163. Kandel ER. The biology of memory: A forty-year perspective. J Neurosci 2009; 29: 12748-12756
164. Mei B, Li F, Gu Y, Cui Z, Tsien JZ. NMDA receptors are not required for pattern completion during associative memory recall. PLoS One 2011; 6: e19326
165. Lemberg A, Eizayaga FX, Vatta M, Dominguez A, Romay S, Bianciotti LG, Sanso G, Fernandez B. Prehepatic portal 178 hypertension in rats modifies norepinephrine metabolism in hypothalamus, medulla oblongata and portal vein. Dig Dis 179 Sci 1993; 38: 1259-1262
166. Arranz CT, Balaszczuk AM, Costa MA, Eizayaga FX, Romay S, Mongelli C, Lemberg A. Systemic baroreflex alterations in prehepatic portal hypertensive conscious rats. Arch Physiol Biochem 1995; 103: 422-426
167. Lemberg A, Perazzo J, Romay S, Eizayaga F, Vatta M, Rodriguez-Fermepin M, Bianciotti L, Monserrat A, Fernandez B.Norepinephrine uptake is enhanced in discrete telencephalic and diencephalic areas and nuclei in prehepatic portal hypertensive rats. Brain Res Bull 1998; 45: 153-156
168. Perazzo JC, Lores-Arnaiz S, Fernandez M, Lago N, Lemberg A. Prehepatic Portal Hipertension and mitochondrial dysfunction in brain hippocampus. In: Haussinger D, Kircheiss 183 G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. London-Heidelberg: Springer, 2006: 190-202
169. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011; 25: 181-213
170. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445-452
171. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC. Control of synaptic strength by glial TNF alpha. Science 2002; 295: 2282-2285
172. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440: 1054-1059
173. Ortiz M, Cordoba J, Jacas C, Flavia M, Esteban R, Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44: 104-110
174. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in e arly hepatic encephalopathy. J Hepatol 2003; 39: 320-325
175. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003; 9: 847-854
176. Powell EM, Mars WM, Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 2001; 30: 79-89
177. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gabele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, Thurman RG. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001; 31: 1544-1549
178. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218
179. Mendez M, Mendez-Lopez M, Lopez L, Aller MA, Arias J, Arias JL. Portosystemic hepatic encephalopathy model shows reversal learning impairment and dysfunction of neural activity in the prefrontal cortex and regions involved in motivated behavior. J Clin Neurosci 2011; 18: 690-694
180. Welzl H, Stork O. Cell adhesion molecules: Key players in memory consolidation? News Physiol Sci 2003; 18: 147-150
181. Monfort P, Munoz MD, Felipo V. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia. Metab Brain Dis 2005; 20: 265-274
182. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004; 84: 87-136
183. Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab Brain Dis 2009; 24: 95-102